X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs UNICHEM LAB - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA UNICHEM LAB ABBOTT INDIA/
UNICHEM LAB
 
P/E (TTM) x 44.2 30.2 146.4% View Chart
P/BV x 11.0 3.2 347.1% View Chart
Dividend Yield % 0.6 0.6 101.8%  

Financials

 ABBOTT INDIA   UNICHEM LAB
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
UNICHEM LAB
Mar-16
ABBOTT INDIA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs6,015334 1,800.9%   
Low Rs3,707174 2,130.5%   
Sales per share (Unadj.) Rs1,236.9146.9 841.9%  
Earnings per share (Unadj.) Rs122.211.9 1,027.3%  
Cash flow per share (Unadj.) Rs129.016.2 796.8%  
Dividends per share (Unadj.) Rs35.002.00 1,750.0%  
Dividend yield (eoy) %0.70.8 91.4%  
Book value per share (Unadj.) Rs521.2105.1 495.9%  
Shares outstanding (eoy) m21.2590.84 23.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.91.7 227.3%   
Avg P/E ratio x39.821.4 186.3%  
P/CF ratio (eoy) x37.715.7 240.2%  
Price / Book Value ratio x9.32.4 385.9%  
Dividend payout %28.616.8 170.4%   
Avg Mkt Cap Rs m103,29623,073 447.7%   
No. of employees `0003.05.7 52.1%   
Total wages/salary Rs m3,3702,558 131.7%   
Avg. sales/employee Rs Th8,891.82,352.5 378.0%   
Avg. wages/employee Rs Th1,140.0450.9 252.8%   
Avg. net profit/employee Rs Th878.3190.4 461.2%   
INCOME DATA
Net Sales Rs m26,28413,346 197.0%  
Other income Rs m504192 262.8%   
Total revenues Rs m26,78913,538 197.9%   
Gross profit Rs m3,6651,639 223.6%  
Depreciation Rs m144390 37.0%   
Interest Rs m829 28.1%   
Profit before tax Rs m4,0171,412 284.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m1,421293 485.5%   
Profit after tax Rs m2,5961,080 240.3%  
Gross profit margin %13.912.3 113.5%  
Effective tax rate %35.420.7 170.6%   
Net profit margin %9.98.1 122.0%  
BALANCE SHEET DATA
Current assets Rs m14,4465,979 241.6%   
Current liabilities Rs m4,7252,432 194.3%   
Net working cap to sales %37.026.6 139.1%  
Current ratio x3.12.5 124.4%  
Inventory Days Days5163 81.5%  
Debtors Days Days2060 32.4%  
Net fixed assets Rs m1,1136,403 17.4%   
Share capital Rs m213182 117.0%   
"Free" reserves Rs m10,8089,293 116.3%   
Net worth Rs m11,0769,548 116.0%   
Long term debt Rs m0230 0.0%   
Total assets Rs m16,24112,843 126.5%  
Interest coverage x497.050.0 993.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.61.0 155.7%   
Return on assets %16.08.6 185.7%  
Return on equity %23.411.3 207.2%  
Return on capital %36.314.3 253.5%  
Exports to sales %0.629.2 2.1%   
Imports to sales %12.66.3 199.2%   
Exports (fob) Rs m1623,900 4.1%   
Imports (cif) Rs m3,322847 392.4%   
Fx inflow Rs m2684,356 6.2%   
Fx outflow Rs m3,9271,162 337.9%   
Net fx Rs m-3,6593,194 -114.6%   
CASH FLOW
From Operations Rs m2,5141,119 224.7%  
From Investments Rs m-800-853 93.7%  
From Financial Activity Rs m-803-334 240.2%  
Net Cashflow Rs m912-68 -1,335.1%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 15.1 52.3%  
FIIs % 0.1 3.0 3.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 31.7 53.9%  
Shareholders   18,270 20,176 90.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 22, 2018 03:03 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS